Hypnosis app shows promise for chronic pain sufferers

NCT ID NCT06050083

First seen Jan 08, 2026 · Last updated Jun 23, 2026 · Updated 25 times

Summary

This study tested a web app called Rose that provides hypnosis audio recordings for people with chronic pain. 100 adults with chronic low back pain or other chronic pain used the app for 8 weeks. The researchers measured how often people used it, their satisfaction, and changes in pain levels. The goal was to see if the app is user-friendly and helpful, with plans to turn it into a mobile app.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Washington, School of Medicine

    Seattle, Washington, 98104, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

hypnosis audio recordings via a web application (Rose)

What this could lead to

If successful, this could lead to a widely available, low-cost digital tool for managing chronic pain at home.

What could go wrong

This is a small, completed feasibility study. The app is not yet proven to reduce pain in a large population, and the investigators have a financial interest in the company developing it.

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.